SAN FRANCISCO, CA / ACCESS Newswire / August 4, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with ...
CASI has already appealed this Determination and requested a hearing on the matter to present a detailed plan to Nasdaq to regain compliance, seeking a further extension of grace period to comply with ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. CASI Pharmaceuticals ( (CASI)) just ...
・As a result of the delisting decision, CASI’s shares will be suspended for trading at the opening of business on Thursday. ・The company stated that it does not intend to review the Nasdaq’s delisting ...
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.
Washington-born duo Casi, formed by Enumclaw's Eli Edwards and Xayvien Young, have announced their signing to Carpark Records, revealed the details of their upcoming debut album, CASI, and shared new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results